Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas

NCT01723306 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

48

Enrollment

OTHER

Sponsor class

Stopped Funding

Conditions

Metastatic Cancers

Interventions

GENETIC: Gene Modified T Cells

Sponsor

Roger Williams Medical Center